Alkermes’ Corporate Presentation to be Webcast at the Credit Suisse Healthcare Conference
Business Wire
Nov 04, 2009
Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live by Credit Suisse on Wednesday,
November 11, 2009, at 5:00 p.m. MT (7:00 p.m. ET) from the Arizona
Biltmore Hotel in Phoenix, Arizona. The presentation may be accessed
under the investor relations tab at www.alkermes.com.
The presentation will be archived for 14 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to
developing innovative medicines to improve patients' lives. Alkermes
developed, manufactures and commercializes VIVITROL® for
alcohol dependence and manufactures RISPERDAL® CONSTA®
for schizophrenia and bipolar I disorder. Alkermes' robust pipeline
includes extended-release injectable, pulmonary and oral products for
the treatment of prevalent, chronic diseases, such as central nervous
system disorders, addiction and diabetes. Headquartered in Cambridge,
Massachusetts, Alkermes has research facilities in Massachusetts and a
commercial manufacturing facility in Ohio.
(c) 2009 Business Wire, Inc., All rights reserved. All of the news releases and other content contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. Any copying or reproduction (other than for an individual user's personal reference), redistribution, reposting or other transmission or communication is expressly prohibited without prior written permission of Business Wire, Inc
